These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of autoimmune blistering diseases in Spain. Suárez R; España A; Herrero-González JE; Iranzo P; Mascaró JM Dermatol Clin; 2011 Oct; 29(4):673-6. PubMed ID: 21925016 [TBL] [Abstract][Full Text] [Related]
4. Approach to the patient with autoimmune mucocutaneous blistering diseases. Sami N Dermatol Ther; 2011; 24(2):173-86. PubMed ID: 21410607 [TBL] [Abstract][Full Text] [Related]
10. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Venning VA Immunol Allergy Clin North Am; 2012 May; 32(2):245-53, vi. PubMed ID: 22560137 [TBL] [Abstract][Full Text] [Related]
11. The blistering diseases. Scott JE; Ahmed AR Med Clin North Am; 1998 Nov; 82(6):1239-83. PubMed ID: 9889748 [TBL] [Abstract][Full Text] [Related]
13. Treating immunobullous diseases: an update. Reynaert S; Black MM Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502 [TBL] [Abstract][Full Text] [Related]
14. What is new in autoimmune vesicobullous disorders? Mahajan R; De D Indian J Dermatol Venereol Leprol; 2011; 77(4):407-12. PubMed ID: 21727687 [No Abstract] [Full Text] [Related]
15. Treatment of autoimmune blistering diseases. Levy M; Rico MJ Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307 [TBL] [Abstract][Full Text] [Related]